mevastatin has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alp, E; Konac, E; Menevse, S; Yilmaz, A | 1 |
| Berthou, L; Chomienne, C; Gueddari, N; Jardillier, JC; Lefebvre, P; Madoulet, C | 1 |
2 other study(ies) available for mevastatin and Leukemia
| Article | Year |
|---|---|
The DNA methyl transferase inhibitor, 5'-aza-2-deoxycitidine, enhances the apoptotic effect of Mevastatin in human leukemia HL-60 cells.
Topics: Apoptosis; Azacitidine; Caspases; Decitabine; DNA Modification Methylases; DNA Replication; Drug Synergism; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; HL-60 Cells; Humans; L-Lactate Dehydrogenase; Leukemia; Lovastatin; Methylation; Microscopy, Fluorescence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |
Partial restoration of all trans retinoic acid (ATRA) sensitivity by compactin in ATRA-resistant leukemic cells (ATRA-R HL-60).
Topics: Antineoplastic Agents; Binding, Competitive; Chromatography, High Pressure Liquid; Drug Interactions; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia; Lovastatin; Receptors, LDL; Tretinoin; Tumor Cells, Cultured | 2000 |